Recombinant avirulent Salmonella vaccine strains with stable maintenance and high level expression of cloned genes in vivo.
about
Cloning of the dapB gene, encoding dihydrodipicolinate reductase, from Mycobacterium tuberculosisCharacterization of a bordetella pertussis diaminopimelate (DAP) biosynthesis locus identifies dapC, a novel gene coding for an N-succinyl-L,L-DAP aminotransferase.Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapyNovel antibiotic-free plasmid selection system based on complementation of host auxotrophy in the NAD de novo synthesis pathwayNovel genetic tools for diaminopimelic acid selection in virulence studies of Yersinia pestis.Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype.Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: persistence and induction of humoral responses in rats.Autodisplay: development of an efficacious system for surface display of antigenic determinants in Salmonella vaccine strains.A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization.Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strainGeneration of influenza virus from avian cells infected by Salmonella carrying the viral genomeOral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.Stable Expression of Lentiviral Antigens by Quality-Controlled Recombinant Mycobacterium bovis BCG VectorsEnteric pathogens as vaccine vectors for foreign antigen deliveryThe Asd(+)-DadB(+) dual-plasmid system offers a novel means to deliver multiple protective antigens by a recombinant attenuated Salmonella vaccineNew technologies in developing recombinant attenuated Salmonella vaccine vectors.Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis.Murine antibody response to oral infection with live aroA recombinant Salmonella dublin vaccine strains expressing filamentous hemagglutinin antigen from Bordetella pertussis.New technologies in using recombinant attenuated Salmonella vaccine vectors.Progress towards a needle-free hepatitis B vaccine.Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa.Enhanced protection against nasopharyngeal carriage of Streptococcus pneumoniae elicited by oral multiantigen DNA vaccines delivered in attenuated Salmonella typhimurium.A diaminopimelic acid auxotrophic Escherichia coli donor provides improved counterselection following intergeneric conjugation with actinomycetes.Conversion of RpoS- Attenuated Salmonella enterica Serovar Typhi Vaccine Strains to RpoS+ Improves Their Resistance to Host Defense Barriers.Comparative evaluation of Salmonella Typhimurium vaccines derived from UK-1 and 14028S: Importance of inherent virulence
P2860
Q28486459-4445C92F-5C00-4427-A67A-457E8C69C562Q30878577-AC72B2ED-A733-4799-BFFD-4E1B1AD4C5EFQ33731187-D18D70AD-6AF6-4885-9A32-BE0B8401CF05Q33768314-4D56AF09-0526-41F8-86E0-BBF3809A088BQ33844730-89B4A363-1C3F-48D6-91A7-3D5435647800Q34126717-1DF996DD-DD5A-4624-A02A-5BAFF50A7B7EQ34532411-79BAFEA4-F281-4156-832F-CF2BB8861C5FQ34851811-253425BF-6689-4CA3-AD08-FE3606895288Q35434055-3C94E731-A35B-4770-8592-C1A6957304E4Q35532132-357738BF-759E-41EC-8E74-7E34142599D0Q35572130-44A28070-94C8-407C-8B55-F193C087B689Q35677333-606A2B43-CFDB-46F9-9581-153D33324657Q35773904-24F9FE3A-7A92-452F-8445-C3499BDF1D44Q35896020-08A2218B-2A95-466A-9E1B-10EAC5B86B9EQ36277335-27BF086E-5DB9-4304-916C-9DCF6D7E8A24Q36653379-99B158E8-8FE6-4E0E-A7E7-E0AC05606BE5Q36747183-4F17C63C-B87E-428B-8CF3-DEA0A77C9BC7Q36986693-C3C349B2-1007-421A-8715-4B2156ACBD54Q37674803-4153760D-DFB8-4C19-B103-19279D36B8D0Q37810816-36EB464F-7A0F-40B3-BBA7-7F6081C26F03Q41065563-76164B27-887C-47E0-A19C-BDBBB50C235DQ50048224-EB2D4097-E8F3-4BA5-9566-0D8D6220F1ADQ53184802-AFEB3B50-DD0C-4646-952D-F6D96803CB55Q53704376-09E58BEA-C258-4527-883D-CFDA606D455DQ58759445-FA9D5589-5A18-46FC-B4F2-8EB3AD638ABF
P2860
Recombinant avirulent Salmonella vaccine strains with stable maintenance and high level expression of cloned genes in vivo.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Recombinant avirulent Salmonel ...... ssion of cloned genes in vivo.
@en
Recombinant avirulent Salmonel ...... ssion of cloned genes in vivo.
@nl
type
label
Recombinant avirulent Salmonel ...... ssion of cloned genes in vivo.
@en
Recombinant avirulent Salmonel ...... ssion of cloned genes in vivo.
@nl
prefLabel
Recombinant avirulent Salmonel ...... ssion of cloned genes in vivo.
@en
Recombinant avirulent Salmonel ...... ssion of cloned genes in vivo.
@nl
P2093
P2860
P1476
Recombinant avirulent Salmonel ...... ssion of cloned genes in vivo.
@en
P2093
Curtiss R 3rd
Nakayama K
P2860
P304
P356
10.3109/08820138909112265
P577
1989-01-01T00:00:00Z